Search Result
Results for "
aspartic acid
" in MedChemExpress (MCE) Product Catalog:
2
Biochemical Assay Reagents
34
Isotope-Labeled Compounds
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-42068
-
(R)-aspartic acid; D-(-)-aspartic acid
|
|
|
(-)-Aspartic acid is an endogenous NMDA receptor agonist.
|
-
-
- HY-42066
-
S)-3-Amino-4-(benzyloxy)-4-oxobutanoic acid; 1-Benzyl L-aspartate; aspartic acid 1-benzyl ester; aspartic acid α-benzyl ester
|
|
|
L-Aspartic acid 1-benzyl ester is an aspartic acid derivative .
|
-
-
- HY-N0666B
-
Calcium L-aspartate
|
Endogenous Metabolite
|
Cardiovascular Disease
|
Aspartic acid calcium (Calcium L-aspartate) is a chelate where calcium is attached to an amino acid naming L-Aspartic acid. L-Aspartic acid is an amino acid and serves as a building block for proteins in the body.
|
-
-
- HY-W142113
-
-
-
- HY-W067478
-
-
-
- HY-113524
-
-
-
- HY-W009503
-
-
-
- HY-42067
-
|
|
|
(tert-Butoxycarbonyl)-D-aspartic acid is an aspartic acid derivative .
|
-
-
- HY-30230
-
-
-
- HY-128696
-
Amlodipine aspartate
|
Drug Metabolite
|
Cardiovascular Disease
|
Amlodipine aspartic acid impurity is the impurity of Amlodipine aspartic acid. Amlodipine aspartic acid is a calcium channel blocker with antihypertensive and antianginal properties.
|
-
-
- HY-W250311
-
|
Biochemical Assay Reagents
|
Others
|
DL-Aspartic acid (hemimagnesium salt is DL-aspartic acid salt. DL-aspartic acid hemimagnesium salt is a commonly used food supplement and food additive, because it can promote the synthesis of protein in the human body, and has a positive effect on the nervous system and The production of cardiovascular system has a certain protective effect. In addition, due to some chemical reactions in the industry, DL-aspartic acid semi-magnesium salt can also be obtained.
|
-
-
- HY-134450
-
-
-
- HY-N0666S10
-
[3-13C]aspartic acid
|
Endogenous Metabolite
|
Cardiovascular Disease
|
L-Aspartic acid- 13C-1 is the deuterium labeled L-Aspartic acid[1]. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly[2][3].
|
-
-
- HY-N0666S2
-
-
-
- HY-N0666S8
-
-
-
- HY-113524S
-
-
-
- HY-N0666S
-
|
Endogenous Metabolite
|
Metabolic Disease
|
L-Aspartic acid- 13C is a 13C labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly[1][2].
|
-
-
- HY-N0666S3
-
-
-
- HY-W015824S
-
-
-
- HY-N0666S4
-
-
-
- HY-N0666
-
-
-
- HY-Y0533
-
L-aspartic acid β-tert-butyl ester; β-tert-Butyl L-aspartate
|
|
|
L-Aspartic acid 4-tert-butyl ester is an aspartic acid derivative .
|
-
-
- HY-N0666A
-
-
-
- HY-N0666S9
-
-
-
- HY-P4301
-
|
Bacterial
|
Infection
|
Di-aspartic acid (Aspartylaspartate) can be utilized as growth substrate for P. gingivalis, P. intermedia, P. nigrescens and F. nucleatum .
|
-
-
- HY-N0666S6
-
-
-
- HY-128425A
-
L-Ureidosuccinic acid
|
Endogenous Metabolite
|
Others
|
N-Carbamoyl-L-aspartic acid is intermediate of pyrimidine (HY-Y0519) metabolism. N-Carbamoyl-L-aspartic acid can be used to measure enzyme activity of dihydroorotase (DHOse) .
|
-
-
- HY-N0666S1
-
|
Endogenous Metabolite
|
Cardiovascular Disease
|
L-Aspartic acid- 13C4, 15N is the 13C-labeled and 15N-labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-128425
-
-
-
- HY-W710495
-
-
-
- HY-118093
-
|
Others
|
Others
|
N-benzoyl-L-aspartic acid, a major metabolite of benzyl glucosinolate, can be used for modification of peptides or proteins .
|
-
-
- HY-W013182
-
-
-
- HY-N0666S5
-
-
-
- HY-N0666S7
-
-
-
- HY-N0666C
-
Sodium L-aspartate
|
Endogenous Metabolite
|
Others
|
L-Aspartic aicd sodium is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly .
|
-
-
- HY-W017500
-
|
iGluR
|
Neurological Disease
|
N-Methyl-DL-aspartic acid is a glutamate analogue and a NMDA receptor agonist and can be used for neurological diseases research .
|
-
-
- HY-Y0028
-
N-(tert-Butoxycarbonyl)aspartic acid 1-benzyl ester; N-(tert-Butoxycarbonyl)aspartic acid benzyl ester
|
Amino Acid Derivatives
|
Others
|
(S)-2-(tert-Butoxycarbonylamino)succinic acid benzyl ester is an aspartic acid derivative .
|
-
-
- HY-W016749S
-
-
-
- HY-N0666D
-
-
-
- HY-139166
-
N-Palmitoyl aspartic acid
|
Others
|
Others
|
N-Palmitoyl-L-aspartate (N-Palmitoyl aspartic acid) is a chiral compound with properties of the aggregates formed in aqueous solution .
|
-
-
- HY-W015824S2
-
-
-
- HY-Y1801
-
L-aspartic acid β-methyl ester hydrochloride
|
Amino Acid Derivatives
|
Others
|
β-Methyl L-aspartate hydrochloride is an aspartic acid derivative .
|
-
-
- HY-W015824S3
-
-
-
- HY-118347
-
|
Others
|
Neurological Disease
|
Aspartame acesulfame is a methyl ester of a dipeptide. Aspartame acesulfame can be used as a synthetic nonnutritive sweetener. Aspartame acesulfame is composed of phenylalanine (50%), aspartic acid (40%) and methanol (10%) .
|
-
-
- HY-W015824S1
-
-
-
- HY-154945
-
-
-
- HY-W015824S5
-
-
-
- HY-17551
-
-
-
- HY-W009328
-
-
-
- HY-42065
-
-
- HY-W016749
-
-
- HY-W018741
-
-
- HY-W008685
-
-
- HY-W041982
-
-
- HY-W010959
-
-
- HY-W011703
-
-
- HY-W008360
-
-
- HY-W017499
-
-
- HY-137950
-
-
- HY-30231
-
-
- HY-W018489
-
-
- HY-W024554
-
-
- HY-W007108
-
-
- HY-W007399
-
-
- HY-W008787
-
-
- HY-Y0029
-
-
- HY-W008075
-
-
- HY-W011553
-
-
- HY-W013145
-
-
- HY-W011278
-
-
- HY-W011126
-
-
- HY-W013291
-
-
- HY-W013659
-
-
- HY-W041996
-
-
- HY-W002326
-
-
- HY-77757
-
-
- HY-W009840
-
-
- HY-W142115
-
-
- HY-W092107
-
-
- HY-W015233
-
-
- HY-42069
-
-
- HY-W004083
-
-
- HY-W142111
-
-
- HY-W013144
-
-
- HY-W011279
-
-
- HY-W041999
-
-
- HY-W013719
-
-
- HY-W013740
-
-
- HY-132841
-
-
- HY-W017501
-
-
- HY-Y1824
-
|
|
|
N-9-Fluorenylmethoxycarbonylaspartic acid β-methyl ester is an aspartic acid derivative .
|
-
- HY-131108
-
L-β-Aspartyl-L-aspartic acid
|
Others
|
Others
|
β-Aspartylaspartic acid is a natural compound found in Asparagus (Asparagus officinalis) Shoots .
|
-
- HY-W002449
-
-
- HY-P4431
-
|
Amino Acid Derivatives
|
Others
|
H-Met-Asp-OH is a dipeptide containing methionine and aspartic acid, which can be used for the synthesis of polypeptides .
|
-
- HY-P4288
-
|
Amino Acid Derivatives
|
Others
|
Beta-Asp-His is a dipeptide containing aspartic acid and histidine, which can form amino acid derivatives by complexing with Zinc .
|
-
- HY-N0667S7
-
(-)-Asparagine-13C4,15N2; Asn-13C4,15N2; Asparamide-13C4,15N2
|
Isotope-Labeled Compounds
|
Others
|
L-Asparagine-13C4,15N2 ((-)-Asparagine-13C4,15N2) is the 13C and 15N-labeled L-Aspartic acid. L-Aspartic acid is an amino acid, shown to be a suitable pro-agent for colon-specific drug delivery .
|
-
- HY-155130
-
|
Parasite
|
Infection
|
Antimalarial agent 31 (compound 7k) is an orally active Plasmodium falciparum aspartic protease plasmepsin X (PMX) inhibitor .
|
-
- HY-P1436
-
|
HIV
|
Infection
|
Acetyl-pepstatin is a potent classical inhibitor of aspartic proteases (PRs) with XMRV PR and HIV-1 PR Ki values of 712 nM and 13 nM .
|
-
- HY-W011324
-
-
- HY-129847
-
|
Others
|
Others
|
Alitame (anhydrous) is a high-intensity sweetener formed from the amino acids L-aspartic acid and D-alanine, and an amine derived from thietane .
|
-
- HY-W007573
-
-
- HY-Z0615
-
Boc-L-Asp(OBn)-OH
|
|
|
(2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid is an aspartic acid derivative .
|
-
- HY-107040
-
NSC 288020; CL-1848C
|
Others
|
Others
|
Etoxadrol (CL-1848C) is a potent N-methyl-D-aspartic acid (NMDA) antagonist with high affinity. Etoxadrol can be used for anaesthetic research .
|
-
- HY-W017069
-
|
Amino Acid Derivatives
|
Others
|
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(allyloxy)-4-oxobutanoic acid is an aspartic acid derivative .
|
-
- HY-W013291A
-
|
Others
|
Others
|
H-D-Asp(OtBu)-OtBu·HCl is the isomer of H-Asp(OtBu)-OtBu.HCl (HY-W013291), and can be used as an experimental control. H-Asp(OtBu)-OtBu.HCl is an aspartic acid derivative .
|
-
- HY-W002301
-
|
Amino Acid Derivatives
|
Others
|
(2S)-4-(benzyloxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid is an aspartic acid derivative .
|
-
- HY-Y0966S1
-
-
- HY-Y0966S8
-
|
Endogenous Metabolite
iGluR
|
Neurological Disease
|
Glycine-d5 is the deuterium labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
- HY-Y0966S10
-
|
Isotope-Labeled Compounds
Endogenous Metabolite
iGluR
|
Cancer
|
Glycine-d3 is the deuterium labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
- HY-B0361S1
-
|
Isotope-Labeled Compounds
|
Neurological Disease
|
Aspartame-d5 is the deuterium labeled Aspartame. Aspartame (SC-18862) is a methyl ester of a dipeptide. Aspartame can be used as a synthetic nonnutritive sweetener. Aspartame is composed of phenylalanine (50%), aspartic acid (40%) and methanol (10%)[1][2].
|
-
- HY-B0361S
-
SC-18862-d3
|
Isotope-Labeled Compounds
|
Neurological Disease
|
Aspartame-d3 is the deuterium labeled Aspartame. Aspartame (SC-18862) is a methyl ester of a dipeptide. Aspartame can be used as a synthetic nonnutritive sweetener. Aspartame is composed of phenylalanine (50%), aspartic acid (40%) and methanol (10%)[1][2].
|
-
- HY-Y0966S3
-
-
- HY-P4290
-
|
Endogenous Metabolite
|
Endocrinology
|
Antiulcer Agent 2 is a tetrapeptide containing aspartic acid, alanine, histidine, and lysine. Antiulcer Agent 2 is present at the N-terminal of human albumin. Antiulcer Agent 2 has potential applications in ulcers and active oxygen generation .
|
-
- HY-Y0966S
-
|
Endogenous Metabolite
iGluR
|
Neurological Disease
|
Glycine- 15N is the 15N-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors[1].
|
-
- HY-Y0966S2
-
|
Endogenous Metabolite
iGluR
|
Neurological Disease
|
Glycine-2- 13C is the 13C-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
- HY-Y0966S4
-
|
Endogenous Metabolite
iGluR
|
Neurological Disease
|
Glycine-1- 13C is the 13C-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
- HY-Y0966S6
-
|
Endogenous Metabolite
iGluR
|
Neurological Disease
|
Glycine- 13C2, 15N is the 13C- and 15N-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
- HY-Y0966S9
-
-
- HY-Y0966S5
-
-
- HY-Y0966S7
-
-
- HY-107031
-
19560 RP
|
iGluR
|
Others
|
Metapramine (19560 RP) is an antidepressant agent, belonging to the class of tricyclic compounds . Metapramine inhibits norepinephrine reuptake, without affecting the reuptake of serotonin or dopamine . Metapramine is a low-affinity antagonist of the N-methyl-D-aspartic acid (NMDA) receptor complex channel .
|
-
- HY-Y0966
-
Glycine
4 Publications Verification
|
Endogenous Metabolite
iGluR
VEGFR
Small Interfering RNA (siRNA)
|
Neurological Disease
|
Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors. Glycine is orally active. Glycine can be used to study cell protection, cancer, neurological diseases, and angiogenesis .
|
-
- HY-P0018
-
Pepstatin
Maximum Cited Publications
26 Publications Verification
Pepstatin A
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin also inhibits HIV protease .
|
-
- HY-P0018A
-
Pepstatin A Trifluoroacetate
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) Trifluoroacetate is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin Trifluoroacetate also inhibits HIV protease .
|
-
- HY-P0018C
-
Pepstatin A acetate
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) acetate is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin acetate also inhibits HIV protease .
|
-
- HY-Y0966S11
-
|
iGluR
Endogenous Metabolite
|
Neurological Disease
|
Glycine- 13C2, 15N,d2 is the deuterium, 13C and 15N labeled Glycine[1]. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors[2].
|
-
- HY-P0018B
-
Pepstatin A Ammonium
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) Ammonium is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin Ammonium also inhibits HIV protease .
|
-
- HY-A0282
-
|
Others
|
Metabolic Disease
Inflammation/Immunology
|
L-Ornithine L-aspartate is a stable salt of two natural nonessential L-amino acids with oral activity: ornithine and aspartic acid. L-Ornithine L-aspartate lowers blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis. L-Ornithine L-aspartate also improves mitochondrial functions .
|
-
- HY-151376
-
|
Proteasome
|
Infection
|
SAP2-IN-1 is a secreted aspartic protease 2 (SAP2) inhibitor and has potent SAP2 inhibitory activity with an IC50 value of 0.92 μM. SAP2-IN-1 also is a virulence factor inhibitor and is inactive in vitro. SAP2-IN-1 can be used for the research of infection .
|
-
- HY-10472
-
|
Beta-secretase
|
Neurological Disease
|
LY2811376 is the first orally available non-peptidic β-secretase (BACE1) inhibitor with IC50 of 239 nM-249 nM, that acts to decrease Aβ secretion with EC50 of 300 nM, and demonstrates to have 10-fold selectivity towards BACE1 over BACE2, and more than 50-fold inhibition over other aspartic proteases including cathepsin D, pepsin, or renin.
|
-
- HY-P3732
-
|
Integrin
|
Cancer
|
RGD-4C is a arginine-glycine-aspartic acid peptide (ACDCRGDCFC) with integrin binding activity. The Arg-Gly-Asp (RGD) sequence serves as the primary integrin recognition site in extracellular matrix proteins, and peptides containing this sequence can mimic the recognition specificity of the matrix proteins. RGD-4C is a αv-integrin ligand, can conjugate with bioactive molecule to exert antitumor effects in animal models .
|
-
- HY-P0109
-
|
|
|
(S,S)-Z-FA-FMK is a cell-permeable, irreversible cathepsin B inhibitor. (S,S)-Z-FA-FMK blocks LPS-induced production of IL-1α and IL-1β. (S,S)-Z-FA-FMK can be used as a negative control for caspase-1 and caspase-2 inhibitors because it lacks an aspartic acid residue at the P1 position .
|
-
Cat. No. |
Product Name |
Type |
-
- HY-P2973
-
Aspergillus acid protease
|
Biochemical Assay Reagents
|
Aspergillopepsin I (Aspergillus acid protease) is an aspartic endopeptidase that catalyses the hydrolysis of peptide bonds in proteins, with broad specificity .
|
-
- HY-W250311
-
|
Biochemical Assay Reagents
|
DL-Aspartic acid (hemimagnesium salt is DL-aspartic acid salt. DL-aspartic acid hemimagnesium salt is a commonly used food supplement and food additive, because it can promote the synthesis of protein in the human body, and has a positive effect on the nervous system and The production of cardiovascular system has a certain protective effect. In addition, due to some chemical reactions in the industry, DL-aspartic acid semi-magnesium salt can also be obtained.
|
Cat. No. |
Product Name |
Target |
Research Area |
- HY-W041999
-
- HY-W013719
-
- HY-W013740
-
- HY-W017501
-
- HY-W002449
-
- HY-P4431
-
|
Amino Acid Derivatives
|
Others
|
H-Met-Asp-OH is a dipeptide containing methionine and aspartic acid, which can be used for the synthesis of polypeptides .
|
- HY-P4288
-
|
Amino Acid Derivatives
|
Others
|
Beta-Asp-His is a dipeptide containing aspartic acid and histidine, which can form amino acid derivatives by complexing with Zinc .
|
- HY-P1436
-
|
HIV
|
Infection
|
Acetyl-pepstatin is a potent classical inhibitor of aspartic proteases (PRs) with XMRV PR and HIV-1 PR Ki values of 712 nM and 13 nM .
|
- HY-W011324
-
- HY-W007573
-
- HY-W017069
-
|
Amino Acid Derivatives
|
Others
|
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(allyloxy)-4-oxobutanoic acid is an aspartic acid derivative .
|
- HY-W002301
-
|
Amino Acid Derivatives
|
Others
|
(2S)-4-(benzyloxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid is an aspartic acid derivative .
|
- HY-P5025
-
Azido-c(RGDyK)
|
Peptides
|
Others
|
Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) (Azido-c(RGDyK)) is a polypeptide composed of arginine, glycine, aspartic acid, and tyrosine that can be used for Synthesis of [ 18F]FPyKYNE-c(RGDyK) .
|
- HY-P4290
-
|
Endogenous Metabolite
|
Endocrinology
|
Antiulcer Agent 2 is a tetrapeptide containing aspartic acid, alanine, histidine, and lysine. Antiulcer Agent 2 is present at the N-terminal of human albumin. Antiulcer Agent 2 has potential applications in ulcers and active oxygen generation .
|
- HY-P4389
-
|
Peptides
|
Metabolic Disease
|
(Asp28)-Glucagon (1-29) (human, rat, porcine) is an optimized structure of glucagon, the 28th position is replaced by aspartic acid (Asp) which significantly increases the aqueous solubility of glucagon in a physiological pH buffer, has the same activity as glucagon .
|
- HY-P3746
-
|
Peptides
|
Inflammation/Immunology
|
Pentigetide is a sythsis pepetide (Asp-Ser-Asp-Pro-Arg or D-S-D-P-R), also know as “HEPP” for “Human IgE Pentapeptide”. Pentigetide can not produce IgE inhibition in several different systems, due to the aspartic acids in HEPP changed into an asparagine .
|
- HY-P0018
-
Pepstatin
Maximum Cited Publications
26 Publications Verification
Pepstatin A
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin also inhibits HIV protease .
|
- HY-P0018A
-
Pepstatin A Trifluoroacetate
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) Trifluoroacetate is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin Trifluoroacetate also inhibits HIV protease .
|
- HY-P0018C
-
Pepstatin A acetate
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) acetate is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin acetate also inhibits HIV protease .
|
- HY-P0018B
-
Pepstatin A Ammonium
|
HIV Protease
Autophagy
|
Infection
Inflammation/Immunology
|
Pepstatin (Pepstatin A) Ammonium is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin Ammonium also inhibits HIV protease .
|
- HY-P5344
-
Fluorigenic PEXEL peptide
|
Peptides
|
Others
|
Dabcyl-LNKRLLHETQ-Edans (Fluorigenic PEXEL peptide) is a biological active peptide. (This FRET substrate peptide for Plasmepsin V (PMV) is derived from the conserved Plasmodium Export Element (PEXEL) motif of Histidine-Rich Protein II (HRPII). PMV is an ER aspartic protease that recognizes and cleaves the RXL sequence within the PEXEL motif of proteins exported by human malaria parasite Plasmodium falciparum, allowing them to translocate into host erythrocytes.)
|
- HY-P3732
-
|
Integrin
|
Cancer
|
RGD-4C is a arginine-glycine-aspartic acid peptide (ACDCRGDCFC) with integrin binding activity. The Arg-Gly-Asp (RGD) sequence serves as the primary integrin recognition site in extracellular matrix proteins, and peptides containing this sequence can mimic the recognition specificity of the matrix proteins. RGD-4C is a αv-integrin ligand, can conjugate with bioactive molecule to exert antitumor effects in animal models .
|
Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
-
- HY-N0666B
-
-
-
- HY-113524
-
-
-
- HY-N0666
-
-
-
- HY-N0666A
-
-
-
- HY-128425A
-
-
-
- HY-128425
-
-
-
- HY-N0666C
-
-
-
- HY-N0666D
-
-
-
- HY-17551
-
-
-
- HY-131108
-
-
-
- HY-Y0966
-
-
-
- HY-P0018
-
Pepstatin
Maximum Cited Publications
26 Publications Verification
Pepstatin A
|
Structural Classification
Natural Products
Microorganisms
Classification of Application Fields
Source classification
Disease Research Fields
Cancer
|
HIV Protease
Autophagy
|
Pepstatin (Pepstatin A) is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin also inhibits HIV protease .
|
-
-
- HY-P0018A
-
Pepstatin A Trifluoroacetate
|
Infection
Structural Classification
Natural Products
Microorganisms
Classification of Application Fields
Source classification
Disease Research Fields
|
HIV Protease
Autophagy
|
Pepstatin (Pepstatin A) Trifluoroacetate is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin Trifluoroacetate also inhibits HIV protease .
|
-
-
- HY-P0018B
-
Pepstatin A Ammonium
|
Infection
Structural Classification
Natural Products
Microorganisms
Classification of Application Fields
Source classification
Disease Research Fields
|
HIV Protease
Autophagy
|
Pepstatin (Pepstatin A) Ammonium is a specific, orally active aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin Ammonium also inhibits HIV protease .
|
-
Cat. No. |
Product Name |
Chemical Structure |
-
- HY-N0666S8
-
|
L-Aspartic acid-d3 is the deuterium labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-113524S
-
|
N-Acetyl-L-aspartic acid-d3 is the deuterium labeled N-Acetyl-L-aspartic acid. N-Acetyl-L-aspartic acid is a derivative of aspartic acid.
|
-
-
- HY-N0666S
-
|
L-Aspartic acid- 13C is a 13C labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly[1][2].
|
-
-
- HY-N0666S10
-
|
L-Aspartic acid- 13C-1 is the deuterium labeled L-Aspartic acid[1]. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly[2][3].
|
-
-
- HY-N0666S2
-
|
DL-Aspartic acid-d3 is the deuterium labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-N0666S3
-
|
L-Aspartic acid- 15N is the 15N-labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly[1].
|
-
-
- HY-W015824S
-
|
DL-Aspartic acid- 13C is the 13C labeled DL-Aspartic acid[1].
|
-
-
- HY-N0666S4
-
|
L-Aspartic acid- 13C4 is the 13C-labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-N0666S9
-
|
L-Aspartic acid- 15N,d3 is the deuterium and 15N-labeled L-Aspartic acid. L-Aspartic acid is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-N0666S6
-
|
L-Aspartic acid-1,4- 13C2 is the 13C-labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-N0666S1
-
|
L-Aspartic acid- 13C4, 15N is the 13C-labeled and 15N-labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-W710495
-
|
N-Acetyl-L-aspartic acid-d3-1is the deuterium labeledN-Acetyl-L-aspartic acid(HY-W710495) .
|
-
-
- HY-N0666S5
-
|
L-Aspartic acid- 13C4, 15N,d3 is the deuterium, 13C-, and 15-labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-N0666S7
-
|
L-Aspartic acid-1,4- 13C2, 15N is the 13C- and 15N-labeled L-Aspartic acid. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly.
|
-
-
- HY-W016749S
-
|
N-Acetyl-DL-aspartic acid-2,3,3-d3 is the deuterium labeled N-Acetyl-DL-aspartic acid-2,3,3[1].
|
-
-
- HY-W015824S2
-
|
DL-Aspartic acid-3- 13C is the 13C labeled DL-Aspartic acid[1].
|
-
-
- HY-W015824S3
-
|
DL-Aspartic acid- 13C1 is the 13C labeled DL-Aspartic acid[1].
|
-
-
- HY-W015824S1
-
|
DL-Aspartic acid- 13C, 15N is the 13C, and 15N-labeled DL-Aspartic acid.
|
-
-
- HY-W015824S5
-
|
DL-Aspartic acid- 13C, 15N-1 hydrochloride is the 13C and 15N labeled DL-Aspartic acid.
|
-
-
- HY-N0667S7
-
|
L-Asparagine-13C4,15N2 ((-)-Asparagine-13C4,15N2) is the 13C and 15N-labeled L-Aspartic acid. L-Aspartic acid is an amino acid, shown to be a suitable pro-agent for colon-specific drug delivery .
|
-
-
- HY-Y0966S1
-
|
Glycine-d2 is the deuterium labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S8
-
|
Glycine-d5 is the deuterium labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S10
-
|
Glycine-d3 is the deuterium labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-B0361S1
-
|
Aspartame-d5 is the deuterium labeled Aspartame. Aspartame (SC-18862) is a methyl ester of a dipeptide. Aspartame can be used as a synthetic nonnutritive sweetener. Aspartame is composed of phenylalanine (50%), aspartic acid (40%) and methanol (10%)[1][2].
|
-
-
- HY-B0361S
-
|
Aspartame-d3 is the deuterium labeled Aspartame. Aspartame (SC-18862) is a methyl ester of a dipeptide. Aspartame can be used as a synthetic nonnutritive sweetener. Aspartame is composed of phenylalanine (50%), aspartic acid (40%) and methanol (10%)[1][2].
|
-
-
- HY-Y0966S3
-
|
Glycine- 13C2 is the 13C-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S
-
|
Glycine- 15N is the 15N-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors[1].
|
-
-
- HY-Y0966S2
-
|
Glycine-2- 13C is the 13C-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S4
-
|
Glycine-1- 13C is the 13C-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S6
-
|
Glycine- 13C2, 15N is the 13C- and 15N-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S9
-
|
Glycine- 15N,d2 is the deuterium and 15N-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S5
-
|
Glycine-1- 13C, 15N is the 13C- and 15N-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S7
-
|
Glycine-2- 13C, 15N is the 13C- and 15N-labeled Glycine. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.
|
-
-
- HY-Y0966S11
-
|
Glycine- 13C2, 15N,d2 is the deuterium, 13C and 15N labeled Glycine[1]. Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors[2].
|
-
Cat. No. |
Product Name |
Application |
Reactivity |
-
- HY-P82169
-
BACE1; BACE; KIAA1149; Beta-secretase 1; Aspartyl protease 2; ASP2; Asp 2; Beta-site amyloid precursor protein cleaving enzyme 1; Beta-site APP cleaving enzyme 1; Memapsin-2; Membrane-associated aspartic protease 2
|
WB, IP
|
Human, Mouse, Rat |
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: